Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Mesothelioma
65%
Mesothelioma Cells
65%
Cap-dependent Translation
53%
Eukaryotic Translation Initiation Factor 4E (eIF4E)
49%
Malignant Mesothelioma
37%
Non-small Cell Lung Cancer Cells
34%
Topoisomerase II
28%
Mediated Translation
27%
Chemosensitivity
27%
Escherichia Coli
26%
Sarcoplasmic Reticulum
26%
EIF4F Complex
26%
Operon
24%
Growth Factors
23%
Gemcitabine
22%
4EGI-1
22%
Insulin-like
22%
Interferon-α (IFN-α)
21%
Cancer Cells
20%
Cell Proliferation
20%
Pemetrexed
20%
Cap-dependent
19%
Antisense Oligonucleotides
18%
4E-BP1
17%
Cell Cycle Regulation
17%
Cis-acting
17%
Escherichia
17%
Acridine
17%
Esophageal Adenocarcinoma
17%
Measles Virus
17%
Gastric Cancer Cell Lines
17%
9-Aminoacridine
17%
Malignant Hyperthermia
17%
Small Molecule Inhibitors
17%
Vesicular Stomatitis Virus
16%
Protein Translation
16%
Catalytic Inhibitor
16%
Lung Cancer Treatment
16%
Induced Apoptosis
16%
Prodrug
15%
Etoposide
14%
Malignancy
14%
Virotherapy
14%
Oncolytic
14%
C-Jun N-terminal Kinase
14%
Cell Viability
13%
Inverted Repeats
13%
Antiproliferative Activity
13%
Vaccine Strain
13%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
58%
Chemosensitivity
31%
Pemetrexed
29%
Gemcitabine
27%
Escherichia coli
26%
Messenger RNA
23%
Operon
22%
Small Molecule
21%
Guanosine Monophosphate
20%
Eukaryotic Initiation Factor
20%
Translation Initiation
18%
Oligonucleotide
18%
Eukaryotic Translation
18%
Antisense
18%
Phosphotransferase
18%
Kinase
18%
Translation (Protein Synthesis)
18%
Cell Cycle Regulation
17%
Promoter Region
16%
DnaA
16%
Inverted Repeat
14%
Wild Type
13%
N-Terminus
13%
Carcinogenesis
13%
Cell Proliferation
13%
Signal Transduction
12%
Cytotoxicity
11%
Bcl-2
11%
Binding Site
10%
Cell Cycle
10%
Fis
10%
Colony Formation
10%
Initiation Factor
9%
Genetics
8%
Anabaena
8%
Stem Cell
8%
Chromosome 20
8%
Receptor Tyrosine Kinase Inhibitors
8%
Epidermal Growth Factor Receptor
8%
Malignant Hyperthermia
8%
AT Rich Sequence
8%
Gene Expression
8%
Isoform
8%
CD44
8%
Chemosensitization
8%
Insulin-Like Growth Factor 1
8%
Tryptamine
8%
Thioredoxin
8%
Halothane
8%
Complex Formation
8%
Pharmacology, Toxicology and Pharmaceutical Science
Mesothelioma
66%
Non Small Cell Lung Cancer
63%
Malignant Neoplasm
40%
DNA Topoisomerase (ATP Hydrolysing)
27%
Interferon
26%
Vesiculovirus
25%
Neoplasm
20%
Initiation Factor 4F
19%
Virotherapy
19%
Aminoacridine Derivative
17%
Acridine
17%
Measles Virus
17%
Lung Cancer
16%
Initiation Factor 4E
16%
Etoposide
13%
Prodrug
11%
Virus Infection
10%
Small Cell Lung Cancer
10%
Vaccine Strain
10%
Gyrase Inhibitor
9%
Ruxolitinib
9%
Pemetrexed
9%
Antisense Oligonucleotide
8%
Cancer Model
8%
Somatomedin C Receptor
8%
Triptolide
8%
Simocyclinone D8
8%
Biological Marker
8%
Phosphotransferase
8%
Malignant Hyperthermia
8%
Measles Vaccine
8%
Esophageal Adenocarcinoma
8%
Ryanodine
8%
Cell Viability
8%
Gemcitabine
7%
Messenger RNA
7%
Enzyme-Linked Immunosorbent Assay
5%
Trastuzumab
5%
Clinical Trial
5%
Western Blot
5%
Combination Therapy
5%
Guava
5%
